Every night on "Mad Money," Jim Cramer offers market commentary and general investment advice, and he makes calls on specific stocks, both of his own choosing and in response to viewer requests. He relies on his many years of experience and strong track record, and he takes full responsibility for his calls.


I never shirk from admitting my mistakes; instead, I dwell on them to learn from them. I change my mind, I take losses, I own up to them

," Cramer has said.

Here we track some of his calls from the previous episode of "Mad Money" and find out, at least in the very short term, how the stocks are performing. Keep in mind that Cramer might not have been recommending that viewers take immediate action on a stock. And, of course, it's up to the individual investor to

do his or her own homework


That said, here's how some of the stocks that Cramer talked about on

Tuesday's "Mad Money" show

fared today.

Charming Shoppes

(CHRS) - Get Report

: Charming Shoppes was Cramer's speculative retail play on Tuesday's show. He said that lower gas prices correspond to higher sales at the retailer. He liked the company's improving fundamentals and said it could be a takeover target. On Wednesday, Charming Shoppes rose 17 cents, or 4.8%, to close at $3.72.


(MKC) - Get Report

: Cramer didn't find much to smile about in spice maker McCormick's most recent quarter, and he worried about competition from


(WMT) - Get Report

. He prefered defensive plays such as


( KFT) and

Action Alerts PLUS


General Mills

(GIS) - Get Report


On Wednesday, McCormick added 18 cents, or 0.6%, to $32.77, while Kraft slipped 5 cents to $25.70, and General Mills fell 56 cents, or 0.9%, to $58.86.

Research In Motion

( RIMM): In his

"Lightning Round" segment

, Cramer said that RIM had "too much competition" and wasn't done going down. On Wednesday, the stock closed down 74 cents, or 1.1%, at $65.62.


(COP) - Get Report

: Conoco is too leveraged to the free-falling natural gas, said Cramer. On Wednesday, it lost 55 cents, or 1.4%, to close at $39.44.



: Cramer said Dendreon's "new drug is for real" and approved of the stock as a speculative pick. On Wednesday, Dendreon closed down $1.30, or 5.4%, at $22.72.

(Editor's note: At the time of publication, Cramer owned General Mills for his Action Alerts PLUS charitable trust.)